Table 2 Clinical endpoints at three-year follow-up.

From: Machine learning insights into thrombo-ischemic risks and bleeding events through platelet lysophospholipids and acylcarnitine species

36 Months follow-up

Ischemic endpoint (n = 25)

Bleeding endpoint (n = 16)

Cardiac death, n (%)

7 (28)

 

Myocardial infarction, n (%)

8 (32)

 

Stroke, n (%)

10 (40)

 

Major bleeding, n (%)

 

16 (100)

Back to article page